A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops

被引:416
作者
Victor, Ronald G. [1 ]
Lynch, Kathleen [1 ]
Li, Ning [2 ]
Blyler, Ciantel [1 ]
Muhammad, Eric [1 ]
Handler, Joel [3 ]
Brettler, Jeffrey [3 ]
Rashid, Mohamad [1 ]
Hsu, Brent [1 ]
Foxx-Drew, Davontae [1 ]
Moy, Norma [1 ]
Reid, Anthony E. [1 ]
Elashoff, Robert M. [2 ]
机构
[1] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA
[3] Kaiser Permanente, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
HYPERTENSION CONTROL; AFRICAN-AMERICANS; OFFICE VISITS; UNITED-STATES; CARE; HEALTH; INTERVENTIONS; COMMUNITY; INDAPAMIDE; GUIDELINES;
D O I
10.1056/NEJMoa1717250
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Uncontrolled hypertension is a major problem among non-Hispanic black men, who are underrepresented in pharmacist intervention trials in traditional health care settings. METHODS We enrolled a cohort of 319 black male patrons with systolic blood pressure of 140 mm Hg or more from 52 black-owned barbershops (nontraditional health care setting) in a cluster-randomized trial in which barbershops were assigned to a pharmacist-led intervention (in which barbers encouraged meetings in barbershops with specialty-trained pharmacists who prescribed drug therapy under a collaborative practice agreement with the participants' doctors) or to an active control approach (in which barbers encouraged lifestyle modification and doctor appointments). The primary outcome was reduction in systolic blood pressure at 6 months. RESULTS At baseline, the mean systolic blood pressure was 152.8 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 6 months, the mean systolic blood pressure fell by 27.0 mm Hg (to 125.8 mm Hg) in the intervention group and by 9.3 mm Hg (to 145.4 mm Hg) in the control group; the mean reduction was 21.6 mm Hg greater with the intervention (95% confidence interval, 14.7 to 28.4; P<0.001). A blood-pressure level of less than 130/80 mm Hg was achieved among 63.6% of the participants in the intervention group versus 11.7% of the participants in the control group (P<0.001). In the intervention group, the rate of cohort retention was 95%, and there were few adverse events (three cases of acute kidney injury). CONCLUSIONS Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in larger blood-pressure reduction when coupled with medication management in barbershops by specialty-trained pharmacists.
引用
收藏
页码:1291 / 1301
页数:11
相关论文
共 37 条
[1]   Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap [J].
Anderegg, Maxwell D. ;
Gums, Tyler H. ;
Uribe, Liz ;
Coffey, Christopher S. ;
James, Paul A. ;
Carter, Barry L. .
HYPERTENSION, 2016, 68 (05) :1314-1320
[2]  
[Anonymous], 2011, CLUSTER ANAL
[3]  
[Anonymous], 2017, CIRCULATION
[4]  
[Anonymous], 2018, CIRCULATION, DOI DOI 10.1161/HYP.0000000000000066
[5]  
[Anonymous], CLUSTER RAN DOMISED
[6]  
Anwar, 1997, Blood Press Monit, V2, P105
[7]   Cardiovascular Health in African Americans A Scientific Statement From the American Heart Association [J].
Carnethon, Mercedes R. ;
Pu, Jia ;
Howard, George ;
Albert, Michelle A. ;
Anderson, Cheryl A. M. ;
Bertoni, Alain G. ;
Mujahid, Mahasin S. ;
Palaniappan, Latha ;
Taylor, Herman A., Jr. ;
Willis, Monte ;
Yancy, Clyde W. .
CIRCULATION, 2017, 136 (21) :E393-E423
[8]   Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones [J].
Carter, Barry L. ;
Ardery, Gail .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (12)
[9]   Primary Care Physician-Pharmacist Collaborative Care Model: Strategies for Implementation [J].
Carter, Barry L. .
PHARMACOTHERAPY, 2016, 36 (04) :363-373
[10]   The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials [J].
Cheema, Ejaz ;
Sutcliffe, Paul ;
Singer, Donald R. J. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (06) :1238-1247